# EXECUTIVE SUMMARY: Objective 1 Assessment

## ✅ OVERALL VERDICT: **THESIS-READY WITH MINOR REFINEMENTS**

Your design is strong, well-justified, and addresses a significant gap in malaria genomics. Main tasks: define metrics, run pilot validation, then scale up.

---

## KEY FINDINGS

### Your Design Strengths
1. ✅ **Novel hypothesis**: IBD is not universally superior for malaria - this is publishable
2. ✅ **Three complementary methods**: IBD, IBS, phylogenetic distance with different assumptions
3. ✅ **Comprehensive parameter space**: 45 scenarios × 20 replicates = 900 simulations
4. ✅ **Clever proxy**: Recombination rate as MOI proxy is justified (with caveats documented)

### Critical Updates Needed
1. ⚠️ **Define "identifiable"** → Use ROC-AUC ≥ 0.80 + Sensitivity ≥ 0.60 @ 90% specificity
2. ⚠️ **Validate ground truth** → Ensure IBD, IBS, phylo use identical pairwise labels
3. ⚠️ **Run pilot first** → Test 3 extreme scenarios before committing to 900 sims
4. ⚠️ **Expand parameters** (optional but recommended) → Add est=1.0, 2.0 and sampling=1%, 2%

---

## PROPOSED IDENTIFIABILITY DEFINITION

**"Identifiable" = ROC-AUC ≥ 0.80 AND Sensitivity ≥ 0.60 at 90% specificity**

### Why This Definition?
- **ROC-AUC**: Standard metric in epidemiology, directly comparable across methods
- **0.80 threshold**: Established cutoff for "good" discrimination in clinical/epi studies
- **Sensitivity at 90% specificity**: Ensures practical utility (detect most cases without false alarms)

### Thresholds Table

| AUC Range | Verdict | Confidence |
|-----------|---------|------------|
| ≥0.90 | **IDENTIFIABLE** | High |
| 0.80-0.89 | **IDENTIFIABLE** | Acceptable |
| 0.70-0.79 | **MARGINAL** | Context-dependent |
| <0.70 | **NOT IDENTIFIABLE** | Poor/Random |

---

## RESEARCH QUESTIONS → METRICS MAPPING

### RQ1: When can methods achieve identifiable inference?
**Metric**: % of scenarios with AUC ≥0.80 for each method  
**Analysis**: Plot AUC vs. recombination rate, sampling proportion, migration rate

### RQ2: Which biological processes most erode identifiability?
**Metric**: Standardized regression coefficients (effect sizes)  
**Analysis**: Fit `AUC ~ rec_rate + bottleneck + est + migration + sampling` for each method

### RQ3: At what migration rate can't we distinguish importation?
**Metric**: AUC for classifying imported vs. local pairs  
**Analysis**: Plot AUC vs. migration rate; find threshold where AUC <0.70

### RQ4: Methodological vs. fundamental failure?
**Metric**: AUC range across methods (max - min)  
**Decision rule**:
- Range <0.10 + all AUC <0.70 → **Fundamental failure**
- Range ≥0.15 + some AUC ≥0.80 → **Methodological failure**

---

## EXPECTED PUBLISHABLE FINDINGS

### Most Likely Result (Testable Prediction)
**"IBD outperforms in high-recombination settings but fails in low-recombination elimination contexts"**

**Supporting evidence you'll generate**:
- Low recombination (1e-9): IBS AUC ~0.88, IBD AUC ~0.68
- High recombination (1e-6): IBD AUC ~0.90, IBS AUC ~0.65
- Crossover point: ~1e-8 (moderate recombination)

**Impact**: Changes practice for malaria elimination surveillance where transmission is declining (→ more clonal)

### Alternative Result
**"No method works below X% sampling"** → Informs surveillance design thresholds

---

## IMMEDIATE ACTION PLAN

### Week 1-2: Validation
1. ✅ Define identifiability (use metrics in Guide document)
2. ✅ Run 3 pilot scenarios:
   - **Easy**: rec=1e-9, sampling=20% (expect all methods AUC >0.85)
   - **Hard**: rec=1e-6, sampling=5% (expect all methods AUC <0.60)
   - **Realistic**: rec=1e-7, sampling=10% (expect method differences)
3. ✅ Verify hypothesis: IBD < IBS for easy scenario, IBD > IBS for hard scenario
4. ✅ Check ground truth consistency across all three methods

### Week 3-4: Refinement
5. ⚠️ (Optional) Expand design: Add est=1.0, 2.0 and sampling=1%, 2%
6. ✅ Document recombination-MOI justification (text provided in review)
7. ✅ Finalize analysis pipeline (template provided)

### Week 5-12: Execution
8. Run full simulation design (can parallelize)
9. Apply inference methods to all scenarios
10. Calculate AUC + sensitivity metrics for all

### Week 13-16: Analysis
11. Generate RQ1-4 figures and tables
12. Fit regression models for parameter effects
13. Identify failure modes

### Week 17-20: Writing
14. Draft manuscript (suggested title: "Rethinking IBD for malaria transmission inference in elimination settings")
15. Thesis chapter

---

## JUSTIFICATION: RECOMBINATION AS MOI PROXY

**Your approach**: Vary recombination rate instead of implementing superinfection in SLiM

**Why this works**:
1. **Biological correlation**: High transmission → both high MOI AND high recombination
2. **Genetic consequence**: Both produce fragmented haplotype blocks (erode IBD signal)
3. **Literature support**: Published Pf recombination rates span 1e-9 (clonal) to 1e-6 (outcrossing)

**Limitations to acknowledge**:
- Doesn't capture temporal MOI accumulation
- Doesn't model within-host competition
- Solution: Frame findings as "recombination-dependent" not "MOI-dependent"

**Text for methods** (provided in full review document):
> "Due to technical constraints in SLiM, we used recombination rate as a proxy for transmission intensity and MOI. This is biologically justified because high-transmission settings exhibit both elevated MOI and increased recombination opportunities..."

---

## DELIVERABLES (WHAT YOU'LL PRODUCE)

### For Thesis
- **Objective 1 chapter**: ~30-40 pages
- **3-4 main figures**: Performance heatmap, ROC curves, phase diagram, parameter effects
- **2-3 supplementary figures**: Additional scenarios, method comparisons
- **1 main table**: Summary statistics by parameter combination

### For Publication
- **First-author paper**: "Limits of IBD-based transmission inference in malaria elimination"
- **Target journals**: PLOS Computational Biology, Genetics, Molecular Biology & Evolution
- **Estimated timeline**: Manuscript draft by Week 20

---

## FILES PROVIDED

1. **objective1_revised_review.md** (18 pages)
   - Comprehensive critical review
   - Detailed justifications
   - Expected results and predictions

2. **identifiability_metrics_guide.md** (9 pages)
   - Quick reference for all metrics
   - Calculation formulas
   - Interpretation thresholds

3. **identifiability_analysis_template.py** (Python script)
   - Working code for all calculations
   - ROC-AUC, sensitivity, method comparison
   - Visualization functions
   - Ready to adapt to your data

4. **THIS FILE** (executive_summary.md)
   - One-page overview
   - Action checklist

---

## FINAL ASSESSMENT

| Component | Grade | Status |
|-----------|-------|--------|
| **Objective statement** | A- | Strong, minor wording suggestions |
| **Research questions** | A | Excellent with defined metrics |
| **Simulation design** | A | Comprehensive parameter coverage |
| **Inference methods** | A | Three complementary approaches |
| **Analysis plan** | B+ | Needs metrics defined (now provided) |
| **Publishability** | A | First-author paper likely |
| **Thesis contribution** | A | Solid Objective 1 chapter |

**Overall: 90/100 - Thesis quality with minor refinements**

---

## CRITICAL SUCCESS FACTOR

**Validate on 3 pilot scenarios BEFORE running 900 simulations**

If pilots don't show expected patterns (IBD vs. IBS reversal at recombination extremes), debug before scaling up. This saves ~6 weeks of computation time.

**Success criteria for pilots**:
- Easy scenario: All methods AUC >0.85 ✓
- Hard scenario: All methods AUC <0.60 ✓
- Realistic scenario: Method differences emerge (AUC range >0.15) ✓
- Hypothesis confirmed: IBS > IBD at low recombination, IBD > IBS at high recombination ✓

If all 4 criteria met → **Proceed with full design**  
If any fail → **Investigate and adjust before scaling**

---

## CONTACT FOR CLARIFICATION

If you need help with:
- Interpreting AUC thresholds → See Metrics Guide Section 1
- Python implementation → See Template Script Sections 2-3
- Justifying recombination proxy → See Review Document Section 3
- Specific research question → See Review Document Section 4
